LAMEA PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin), By End-user, By Application, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa PEGylated Proteins Market would witness market growth of 14.4% CAGR during the forecast period (2022-2028).

The pharmacological benefits and relevance of PEGylation of proteins also include greater drug stability, little loss of biological activity, decreased dosage frequency, and improved drug solubility. Cimzia, Macugen, Mircera, Somavert, Neulasta, and Pegasys are some of the pegylated medications that the FDA has approved. These medications are effective in the treatment of a wide range of conditions, including Crohn's disease, anemia in chronic renal disease, Acromegaly, age-related macular degeneration, hepatitis C, and neutropenia during chemotherapy.

PEG molecules are utilized in the conjugation of nanoparticles for anti-cancer medication delivery systems. By regulating the discharge of native protein from the conjugates into the circulation, the controlled releasable PEGs have been designed to prevent any loss of efficacy. The care of various chronic diseases, such as cancer, leukemia, rheumatoid arthritis, severe combined immunodeficiency disease, Crohn's disease, and hepatitis C, has been improved by the PEGylation of therapeutic proteins.

The most significant PEGylated medications are pegfilgrastim, pegaspargase, certolizumab pegol, pegademase bovine, pegvisomant, pegaptanib, and interferons. Determining clinically meaningful anti-PEG antibody titers is necessary to control the risk of adverse events following patient exposure to PEGylated medications since the formation of anti-PEG antibodies may decrease the efficacy and safety of PEGylated therapies.

The region's HIV epidemic is still predominantly concentrated in at-risk groups, with MSM and transgender women (TGW) bearing the brunt of the disease. The difficulties of late commencement and inadequate adherence to treatment continue. Regarding prevention, new research on PrEP willingness in important populations has yielded encouraging findings. At the same time, national health systems are increasingly adopting PrEP through implementation projects. Brazil's first year of offering PrEP in numerous cities across the entire nation provides a peek at real-world PrEP uptake.

The Brazil market dominated the LAMEA PEGylated Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $38.1 million by 2028.The Argentina market is exhibiting a CAGR of 15% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 14.1% during (2022 - 2028).

Based on Product & Services, the market is segmented into Consumables and Services. Based on Type, the market is segmented into Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on Application, the market is segmented into Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global PEGylated Proteins Market is Predict to reach $2.1 Billion by 2028, at a CAGR of 11.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Millipore (Merck KGaA), Thermo Fisher Scientific, Inc., NOF Corporation, JenKem Technology Co. Ltd., Creative PEGworks, Celares GmbH, Quanta BioDesign, Ltd., Biomatrik, Inc., Iris Biotech GmbH, and Laysan Bio, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product & Services

• Consumables
• Services

By Type

• Colony-stimulating Factor
• Interferons
• Recombinant Factor VII
• Erythropoietin
• Others

By End-user

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes

By Application

• Cancer
• Autoimmune Diseases
• Hepatitis
• Multiple Sclerosis
• Hemophilia
• Gastrointestinal Disorders
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Merck Millipore (Merck KGaA)
• Thermo Fisher Scientific, Inc.
• NOF Corporation
• JenKem Technology Co. Ltd.
• Creative PEGworks
• Celares GmbH
• Quanta BioDesign, Ltd.
• Biomatrik, Inc.
• Iris Biotech GmbH
• Laysan Bio, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA PEGylated Proteins Market, by Product & Services
1.4.2 LAMEA PEGylated Proteins Market, by Type
1.4.3 LAMEA PEGylated Proteins Market, by End-user
1.4.4 LAMEA PEGylated Proteins Market, by Application
1.4.5 LAMEA PEGylated Proteins Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in PEGylated Proteins Market

Chapter 4. LAMEA PEGylated Proteins Market by Product & Services
4.1 LAMEA Consumables Market by Country
4.2 LAMEA Services Market by Country

Chapter 5. LAMEA PEGylated Proteins Market by Type
5.1 LAMEA Colony-stimulating Factor Market by Country
5.2 LAMEA Interferons Market by Country
5.3 LAMEA Recombinant Factor VII Market by Country
5.4 LAMEA Erythropoietin Market by Country
5.5 LAMEA Others Market by Country

Chapter 6. LAMEA PEGylated Proteins Market by End-user
6.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
6.2 LAMEA Contract Research Organizations (CROs) Market by Country
6.3 LAMEA Academic & Research Institutes Market by Country

Chapter 7. LAMEA PEGylated Proteins Market by Application
7.1 LAMEA Cancer Market by Country
7.2 LAMEA Autoimmune Diseases Market by Country
7.3 LAMEA Hepatitis Market by Country
7.4 LAMEA Multiple Sclerosis Market by Country
7.5 LAMEA Hemophilia Market by Country
7.6 LAMEA Gastrointestinal Disorders Market by Country
7.7 LAMEA Others Market by Country

Chapter 8. LAMEA PEGylated Proteins Market by Country
8.1 Brazil PEGylated Proteins Market
8.1.1 Brazil PEGylated Proteins Market by Product & Services
8.1.2 Brazil PEGylated Proteins Market by Type
8.1.3 Brazil PEGylated Proteins Market by End-user
8.1.4 Brazil PEGylated Proteins Market by Application
8.2 Argentina PEGylated Proteins Market
8.2.1 Argentina PEGylated Proteins Market by Product & Services
8.2.2 Argentina PEGylated Proteins Market by Type
8.2.3 Argentina PEGylated Proteins Market by End-user
8.2.4 Argentina PEGylated Proteins Market by Application
8.3 UAE PEGylated Proteins Market
8.3.1 UAE PEGylated Proteins Market by Product & Services
8.3.2 UAE PEGylated Proteins Market by Type
8.3.3 UAE PEGylated Proteins Market by End-user
8.3.4 UAE PEGylated Proteins Market by Application
8.4 Saudi Arabia PEGylated Proteins Market
8.4.1 Saudi Arabia PEGylated Proteins Market by Product & Services
8.4.2 Saudi Arabia PEGylated Proteins Market by Type
8.4.3 Saudi Arabia PEGylated Proteins Market by End-user
8.4.4 Saudi Arabia PEGylated Proteins Market by Application
8.5 South Africa PEGylated Proteins Market
8.5.1 South Africa PEGylated Proteins Market by Product & Services
8.5.2 South Africa PEGylated Proteins Market by Type
8.5.3 South Africa PEGylated Proteins Market by End-user
8.5.4 South Africa PEGylated Proteins Market by Application
8.6 Nigeria PEGylated Proteins Market
8.6.1 Nigeria PEGylated Proteins Market by Product & Services
8.6.2 Nigeria PEGylated Proteins Market by Type
8.6.3 Nigeria PEGylated Proteins Market by End-user
8.6.4 Nigeria PEGylated Proteins Market by Application
8.7 Rest of LAMEA PEGylated Proteins Market
8.7.1 Rest of LAMEA PEGylated Proteins Market by Product & Services
8.7.2 Rest of LAMEA PEGylated Proteins Market by Type
8.7.3 Rest of LAMEA PEGylated Proteins Market by End-user
8.7.4 Rest of LAMEA PEGylated Proteins Market by Application

Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.2 Merck Millipore ( Merck Group)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 NOF Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Beijing Jiankai Technology Co., Ltd. (Jenkem)
9.4.1 Company Overview
9.5 Creative PEGworks
9.5.1 Company Overview
9.6 Celares GmbH
9.6.1 Company Overview
9.7 Quanta BioDesign Ltd.
9.7.1 Company Overview
9.8 Biomatrik, Inc.
9.8.1 Company Overview
9.9 Iris Biotech GmbH
9.9.1 Company Overview
9.10. Laysan Bio, Inc.
9.10.1 Company Overview

TABLE 1 LAMEA PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 2 LAMEA PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 3 LAMEA PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 4 LAMEA PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 5 LAMEA Consumables Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Consumables Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 10 LAMEA PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 11 LAMEA Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Interferons Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Interferons Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 22 LAMEA PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 23 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 30 LAMEA PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 31 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 47 Brazil PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 48 Brazil PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 49 Brazil PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 50 Brazil PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 51 Brazil PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 52 Brazil PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 53 Brazil PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 54 Brazil PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 55 Brazil PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 56 Brazil PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 57 Argentina PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 58 Argentina PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 59 Argentina PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 60 Argentina PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 61 Argentina PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 62 Argentina PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 63 Argentina PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 64 Argentina PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 65 Argentina PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 66 Argentina PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 67 UAE PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 68 UAE PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 69 UAE PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 70 UAE PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 71 UAE PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 72 UAE PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 73 UAE PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 74 UAE PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 75 UAE PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 76 UAE PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 77 Saudi Arabia PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 78 Saudi Arabia PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 79 Saudi Arabia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 80 Saudi Arabia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 81 Saudi Arabia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 82 Saudi Arabia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 83 Saudi Arabia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 84 Saudi Arabia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 85 Saudi Arabia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 86 Saudi Arabia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 87 South Africa PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 88 South Africa PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 89 South Africa PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 90 South Africa PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 91 South Africa PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 92 South Africa PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 93 South Africa PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 94 South Africa PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 95 South Africa PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 96 South Africa PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 97 Nigeria PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 98 Nigeria PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 99 Nigeria PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 100 Nigeria PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 101 Nigeria PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 102 Nigeria PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 103 Nigeria PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 104 Nigeria PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 105 Nigeria PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 106 Nigeria PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 107 Rest of LAMEA PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 108 Rest of LAMEA PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 109 Rest of LAMEA PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 110 Rest of LAMEA PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 111 Rest of LAMEA PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 112 Rest of LAMEA PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 113 Rest of LAMEA PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 114 Rest of LAMEA PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 115 Rest of LAMEA PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 116 Rest of LAMEA PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 117 Key Information – Thermo Fisher Scientific, Inc.
TABLE 118 Key Information – Merck Millipore
TABLE 119 Key Information – nof corporation
TABLE 120 Key Information – Beijing Jiankai Technology Co., Ltd.
TABLE 121 Key Information – Creative PEGworks
TABLE 122 Key Information – Celares gmbh
TABLE 123 Key Information –Quanta biodesign ltd.
TABLE 124 Key Information – biomatrik, inc.
TABLE 125 Key Information – Iris biotech gmbh
TABLE 126 Key Information – laysan bio, inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Thermo Fisher Scientific, Inc.